This is a multi-centre, observational, non-interventional study. Patients with metastatic colorectal cancer eligible for Bevacizumab in combination with chemotherapy treatment will be enrolled in this trial.
To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer